Literature DB >> 12814143

The diffusing capacity in adult cystic fibrosis.

J D Espiritu1, G Ruppel, Y Shrestha, M E Kleinhenz.   

Abstract

The value of adjusting the diffusing capacity for the lung volume has been demonstrated in a large number of patients with other lung diseases but has not been validated in patients with cystic fibrosis (CF). Pulmonary function test results on a cohort of 52 adult CF patients were analyzed to determine whether the diffusing capacity of carbon monoxide by single breath method (DLCO(SB)) when adjusted for alveolar volume (V(A)%), correlated with the severity of pulmonary dysfunction. The DLCO(SB) remained within the reference range except in those with severe lung impairment (61.88 +/- 15.48%). DLCO(SB) has a significant (P < 0.05) positive correlation (0.70, 0.67, 048, 0.69 and 0.31, respectively) with measures of airflow limitation (FVC%, FEV1%, FEV1/FVC%, MVV%, and sGaw) and negative correlation (-0.36 and -0.21, respectively) with measures of air trapping (RV% and RV/TLC%). DLCO(SB)/V(A) remained above 100% of predicted despite worsening lung disease and did not correlate with other measures of lung function. On the other hand, the DLCO(SB) and DLCO(SB)/V(A), when adjusted for V(A)%, decreased and were significantly correlated with worsening airflow limitation and, to a lesser extent, air trapping. The relatively preserved adjusted DLCO(SB) and DLCO(SB)/V(A) values in CF patients up until late in its course may be explained the predominant airway involvement, minimal loss of alveolar-capillary units, and enhanced V/Q relationship due to claustration in CF.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12814143     DOI: 10.1053/rmed.2003.1487

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  3 in total

1.  Prognosis-Based Early Intervention Strategies to Resolve Exacerbation and Progressive Lung Function Decline in Cystic Fibrosis.

Authors:  Neeraj Vij
Journal:  J Pers Med       Date:  2021-02-03

2.  Lung diffusing capacity for nitric oxide and carbon monoxide in relation to morphological changes as assessed by computed tomography in patients with cystic fibrosis.

Authors:  Holger Dressel; Laura Filser; Rainald Fischer; Katharina Marten; Ullrich Müller-Lisse; Dorothea de la Motte; Dennis Nowak; Rudolf M Huber; Rudolf A Jörres
Journal:  BMC Pulm Med       Date:  2009-06-16       Impact factor: 3.317

3.  Exhaled breath condensate detects baseline reductions in chloride and increases in response to albuterol in cystic fibrosis patients.

Authors:  Courtney M Wheatley; Wayne J Morgan; Nicholas A Cassuto; William T Foxx-Lupo; Cori L Daines; Mary A Morgan; Hanna Phan; Eric M Snyder
Journal:  Clin Med Insights Circ Respir Pulm Med       Date:  2013-12-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.